Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For young people (ages 10–13) and their parent or guardian:
- The young person has been diagnosed with type 1 diabetes (according to standard medical guidelines) for at least 6 months
- The young person is between 10 and 13 years old at the time of signing consent
- The young person and/or their parent or guardian speaks English or Spanish
- The young person has had at least one blood sugar control test result (called a hemoglobin A1c) of 7.5% or higher in the past 12 months
- The young person is already a patient at one of the clinics taking part in the study
- The parent or legal guardian is at least 18 years old at the time of signing consent
- The parent or legal guardian has regular access to a mobile phone that can send text messages, and a device with internet access
For teenagers (ages 14–17) contributing to video content:
- The teenager has had type 1 diabetes for at least 1 year (self-reported)
- The teenager is between 14 and 17 years old at the time of signing consent
- The teenager speaks English
- The teenager lives in the United States
For diabetes care providers:
- The provider works at one of the diabetes care centres involved in the study
Who may not be able to join:
For young people (ages 10–13):
- Currently being treated for a serious or significant ongoing medical condition alongside diabetes (such as cancer or cystic fibrosis)
- Currently being treated for a serious or significant mental health or psychiatric condition
- Currently being treated for a serious or significant developmental condition that could affect the young person's ability to understand and take part, or that could affect study results
For parents or legal guardians:
- Currently being treated for a serious or significant ongoing medical condition (such as cancer or cystic fibrosis)
- Currently being treated for a serious or significant mental health or psychiatric condition
- Currently being treated for a serious or significant developmental condition that could affect their ability to understand and take part, or that could affect study results
Other reasons a family may not be able to join:
- The family plans to move the young person's diabetes care to a different hospital or clinic within the next 6 months
- The legal guardianship of the young person with diabetes is unclear at the time of screening or recruitment
- The study team becomes aware of involvement with the legal system during the screening or recruitment process (confirm with trial site)
For teenagers contributing to video content:
- The teenager or their parent has a significant psychiatric or developmental condition that would interfere with the ability to understand and take part
- The teenager has a significant other medical condition alongside diabetes (such as cancer or cystic fibrosis) that could affect study results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marisa Hilliard, PhD, Baylor College of Medicine
Phone: 832-824-7209
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Demographic and Medical Information Questionnaire; Glycemic Control - HbA1c; Glycemic Control - time-in-range; Adherence - Self-Care Inventory 2 (SCI-2); Health-Related Quality of Life (HRQOL)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.